New pill to treat Multiple Sclerosis may be available soon, says drugmaker Merck
Associated Press - Star Tribune
Last update: January 23, 2009


LONDON - German drugmaker Merck Serono is one step closer to releasing the first pill to treat multiple sclerosis, the company said Friday.

In a press statement, Merck said that patients taking cladribine tablets had a nearly 60 percent lower relapse rate than those on placebo pills. The two-year study included 1,326 MS patients who were randomly divided into three groups. Two groups received different doses of cladribine and one group received fake pills.

» Read More